Anzeige
Mehr »
Donnerstag, 24.07.2025 - Börsentäglich über 12.000 News
Lizenz aktiviert - Kooperation fix: Diese Aktie will jetzt den Milliardenmarkt erobern!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40S5K | ISIN: US90138Q3065 | Ticker-Symbol:
NASDAQ
28.03.25 | 20:43
0,630 US-Dollar
-18,16 % -0,140
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
23ANDME HOLDING CO Chart 1 Jahr
5-Tage-Chart
23ANDME HOLDING CO 5-Tage-Chart

Aktuelle News zur 23ANDME Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.07.23andMe Holding Co. - 8-K, Current Report2
14.07.23andMe, Inc.: TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets196SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- TTAM Research Institute ("TTAM"), a nonprofit public benefit corporation based in California and founded and led by Anne Wojcicki, today announced...
► Artikel lesen
08.07.California fails to stop 23andMe founder from re-acquiring company1
23ANDME Aktie jetzt für 0€ handeln
02.07.23andMe's new owner says your DNA is safe this time2
02.07.Anne Wojcicki's non-profit gets court approval to buy 23andMe for US$305 million2
01.07.Non-profit run by 23andMe co-founder gets court approval to buy the genetic testing company1
01.07.Anne Wojcicki's nonprofit gets court approval to buy 23andMe for $305 million1
30.06.23andMe Holding Co. - 8-K, Current Report1
30.06.23andMe, Inc.: 23andMe Receives Court Approval for Sale to TTAM Research Institute, a Nonprofit Public Benefit Corporation209SAN FRANCISCO, June 30, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. ("23andMe" or the "Company") (OTC: MEHCQ), a genetics-led consumer healthcare company, today announced that it has received approval...
► Artikel lesen
23.06.UK Fines 23andMe Over Mishandling of Sensitive Genetic Data1
20.06.From $6B Valuation to Bankruptcy to Rescue: Wojcicki Reclaims 23andMe for $305M2
17.06.UK Regulators Fine 23andMe Over Massive Genetic Data Breach1
17.06.23andMe co-founder wins bid to take back control of company1
17.06.ICO fines bankrupt 23andMe £2.3m for massive privacy breach1
17.06.Genetic testing firm 23andMe fined millions for failing to protect customer data1
17.06.FDA clears CSL's swelling disease drug; Regeneron loses 23andMe auction7
17.06.DNA testing firm 23andMe fined £2.3m by UK regulator for 2023 data hack2
17.06.UK watchdog fines 23andMe for 'profoundly damaging' data breach-
17.06.UK watchdog fines 23andMe over 2023 data breach-
17.06.23andMe fined £2.31m over UK users' genetic data breach-
Weiter >>
227 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1